GUARDION HEALTH SCIENCES, INC. Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K/A)

Item 7.01 Regulation FD Disclosure

On January 10, 2022, Guardion Health Sciences, Inc. (the "Company") will make a presentation (the "Presentation") at the H.C. Wainwright Bioconnect 2022 Virtual Conference. The Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 PowerPoint Presentation, dated January 2022

104 Inline XBRL for the cover page of this Current Report on Form 8-K

-2-

© Edgar Online, source Glimpses